UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 26, 2014
PHYSICIANS REALTY TRUST
(Exact name of registrant as specified in its charter)
Maryland incorporation or organization) |
|
001-36007 |
|
46-2519850 |
735 N. Water Street, Suite 1000 Milwaukee, Wisconsin |
|
53202 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (414) 978-6494
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On September 26, 2014, Physicians Realty Trust (the Company) issued a press release announcing that the Board of Trustees declared a quarterly cash dividend of $0.225 per common share for the quarter ending Sepetember 30, 2014. The dividend will be payable on October 30, 2014, to common shareholders of record on October 17, 2014. A copy of the Companys press release is filed as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statement and Exhibits.
(d) Exhibit 99.1 is attached to this 8-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 26, 2014 |
PHYSICIANS REALTY TRUST | |
|
| |
|
| |
|
By: |
/s/ John T. Thomas |
|
|
John T. Thomas |
|
|
President and Chief Executive Officer |